Neuroleptic withdrawal in schizophrenic patients: A review of the literature

Archives of General Psychiatry

Volumn 52, Issue 3, 1995, Pages 173-212

  Gilbert, P L ^a   Harris, M J ^a   McAdams, L A ^a   Jeste, D V ^a   Baldessarini, R J ^a   Viguera, A C ^a   Carpenter Jr , W T ^a   Tamminga, C A ^a   Greden, J F ^a   Tandon, R ^a   Meltzer, H Y ^a   Nuechterlein, K H ^a   Gitlin, M J ^a   Subotnik, K L ^a   Wyatt, R J ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CHLORPROTHIXENE; FLUPHENAZINE DECANOATE; HALOPERIDOL; NEUROLEPTIC AGENT; PENFLURIDOL; PERPHENAZINE; PHENOTHIAZINE DERIVATIVE; THIORIDAZINE; TRIFLUOPERAZINE;

ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAPHORESIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG WITHDRAWAL; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; INTELLIGENCE TEST; MAJOR CLINICAL STUDY; MALAISE; MALE; MORBIDITY; PARKINSONISM; PATIENT COMPLIANCE; RATING SCALE; RELAPSE; REVIEW; SCHIZOIDISM; SCHIZOPHRENIA; STATISTICAL ANALYSIS; TARDIVE DYSKINESIA; TREATMENT PLANNING;

EID: 0028916857     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1995.03950150005001     Document Type: Review

References (0)